Evaluation of the Hospitalized Coronavirus Disease 2019 Patients in First 3 Months of the Pandemic

Basit Öğe Kaydı
dc.authoridALKAN, Sevil/0000-0003-1944-2477
dc.contributor.authorAlkan, Sevil
dc.contributor.authorAkca, Anil
dc.contributor.authorSener, Alper
dc.contributor.authorDogan, Ebru
dc.contributor.authorGonlugur, Ugur
dc.contributor.authorSimsek, Tuncer
dc.contributor.authorOzer, Sule
dc.date.accessioned2025-01-27T21:21:16Z
dc.date.available2025-01-27T21:21:16Z
dc.date.issued2022
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractOBJECTIVE: Data about Turkish coronavirus disease 2019 patients are limited. We evaluated hospitalized coronavirus disease 2019 patients who were followed up in the first 3 months of the pandemic. MATERIAL AND METHODS: This retrospective, single-center, observational study included 415 confirmed hospitalized coronavirus disease 2019 patients. The patients were divided into groups, namely, mild, moderate, and critically ill patients. Symptoms at the time of admission, clinical, laboratory, and imaging findings were examined. RESULTS: In our study, 6.74% of coronavirus disease 2019 patients had severe disease, 59.5% were male, and the mortality rate was 11.3%. Diabetes mellitus and chronic obstructive pulmonary disease were more frequently seen in critically ill patient groups and hyper- tension in moderate patient groups. Anemia and aspartate aminotransferase levels were higher in non-survivors among mild coronavirus disease 2019 patients. In the moderate patients' group, aspartate aminotransferase, lactate dehydrogenase, international normalized ratio, ferritin, and D-dimer levels were higher and lymphocyte, hemoglobin levels were lower; in the critically ill patients' group, platelets were lower and uric acid levels were higher in non-survivor patients. CONCLUSION: In mild patients, anemia, lymphopenia, and increased aspartate aminotransferase levels; in moderate patients, leukopenia, anemia, and increased aspartate aminotransferase, lactate dehydrogenase, international normalized ratio, ferritin, and D-dimer levels; in the critically ill patient group, lower platelet and increased uric acid levels should he followed closely as they are mortality predictors.
dc.identifier.doi10.5152/TurkThoracJ.2022.21118
dc.identifier.endpage57
dc.identifier.issn2149-2530
dc.identifier.issue1
dc.identifier.pmid35110201
dc.identifier.scopus2-s2.0-85123045225
dc.identifier.scopusqualityN/A
dc.identifier.startpage52
dc.identifier.trdizinid1170926
dc.identifier.urihttps://doi.org/10.5152/TurkThoracJ.2022.21118
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1170926
dc.identifier.urihttps://hdl.handle.net/20.500.12428/28868
dc.identifier.volume23
dc.identifier.wosWOS:000749735200010
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherAves
dc.relation.ispartofTurkish Thoracic Journal
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectCOVID-19
dc.subjectdisease severity
dc.subjectmortality
dc.subjectsymptoms
dc.titleEvaluation of the Hospitalized Coronavirus Disease 2019 Patients in First 3 Months of the Pandemic
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu